Breaking News

     >>>>> Chief Minister N. Biren graces First “Go To Hills” program of 2021 in Kamjong District Headquarter; unveils 12 Projects and lays foundation stones for 11 New projects >>     >>>>> Prime Minister Narendra Modi will launch world's largest COVID-19 vaccination program in India tomorrow morning via video conferencing >>>>>>     >>>>>>>>>New Impact Bouquet available from September 2020 >>>>>     >>>>>>>> India records 15 Thousand 590 new COVID-19 cases taking country's tally above One crore 5 Lakh 27 Thousand; recovery rate stands above 96 per cent >>>>>>     >>>> 15-day Special Handloom Expo 2021, organised by Directorate of Handlooms & Textiles since January 1st at Urban Haat in Nilakuthi concluded today >>>>>     >>>>> A combined team of Imphal East Narcotic Cell and YADA members have arrested a woman drug pedlar in possession of contraband 74 WY Tablets and 15 grams of Heroin No.4 Powder at Checkon Chassad Avenue in Imphal East District >>>>>

Serum Institute of India says 200 to 300 million of Covid-19 vaccine doses may be ready In india by December end

Imphal, 18 October 2020 ( Evening News ) : Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill & Melinda Gates Foundation will accelerate the manufacture and delivery of up to 200 million to 300 million doses of safe and effective COVID-19 vaccines for India and low-and middle-income countries by December. Executive Director of Serum Institute of India, Dr.Suresh Jadhav said that India may get COVID-19 vaccine by March 2021 with approval from the Drug Control General of India (DCGI) and provided the regulators signal with the processes fast as multiple manufacturers are working on it. It may be mentioned that SIL CEO Adar Poonawala Serum had earlier said that SIL can produce 700 to 800 million vaccine dosages every year once things are streamlined. Pune-based pharmaceutical company, SIL signed a deal with Malinda Gates Foundation and Gavi Vaccine Alliance to make over 200 million COVID 19 vaccine doses available for poorer countries, including India, to be priced at a maximum of 3 dollars each, which is 220.33 Indian Rupees. It may be mentioned that the phase- three or the last stage of clinical trial of the Covid-19 vaccine 'COVI-SHIELD', being developed by Oxford University, and manufactured by the Serum Institute of India (SII) is currently underway.

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.

« January 2021 »
Mon Tue Wed Thu Fri Sat Sun
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Media Partners